Phase 1 Study
The Phase 1 study of dutogliptin evaluated safety, pharmacokinetics and pharmacodynamics in healthy volunteers after single and repeated parenteral application.
Status of Study
Enrolment completed in 09.2017 at the University Hospital of Vienna, Austria.
This study was designed with nine cohorts and was an open-label, single center study evaluating the safety, pharmacokinetics and pharmacodynamics of parenterally administered dutogliptin in healthy volunteers.